These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 21848578

  • 1. Temporal changes in hospital costs for left ventricular assist device implantation.
    Slaughter MS, Bostic R, Tong K, Russo M, Rogers JG.
    J Card Surg; 2011 Sep; 26(5):535-41. PubMed ID: 21848578
    [Abstract] [Full Text] [Related]

  • 2. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.
    Miller LW, Nelson KE, Bostic RR, Tong K, Slaughter MS, Long JW.
    J Heart Lung Transplant; 2006 Jul; 25(7):778-84. PubMed ID: 16818120
    [Abstract] [Full Text] [Related]

  • 3. Heart transplant and left ventricular assist device costs.
    Digiorgi PL, Reel MS, Thornton B, Burton E, Naka Y, Oz MC.
    J Heart Lung Transplant; 2005 Feb; 24(2):200-4. PubMed ID: 15701438
    [Abstract] [Full Text] [Related]

  • 4. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW, Healy AH, Rasmusson BY, Cowley CG, Nelson KE, Kfoury AG, Clayson SE, Reid BB, Moore SA, Blank DU, Renlund DG.
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
    Rogers JG, Bostic RR, Tong KB, Adamson R, Russo M, Slaughter MS.
    Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW.
    Circulation; 2007 Jul 31; 116(5):497-505. PubMed ID: 17638928
    [Abstract] [Full Text] [Related]

  • 7. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.
    J Thorac Cardiovasc Surg; 2010 Jul 31; 140(1):174-81. PubMed ID: 20447659
    [Abstract] [Full Text] [Related]

  • 8. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support.
    Petrucci RJ, Rogers JG, Blue L, Gallagher C, Russell SD, Dordunoo D, Jaski BE, Chillcott S, Sun B, Yanssens TL, Tatooles A, Koundakjian L, Farrar DJ, Slaughter MS.
    J Heart Lung Transplant; 2012 Jan 31; 31(1):27-36. PubMed ID: 22153550
    [Abstract] [Full Text] [Related]

  • 9. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.
    Ann Thorac Surg; 2008 Oct 31; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [Abstract] [Full Text] [Related]

  • 10. Costs and reimbursement gaps after implementation of third-generation left ventricular assist devices.
    Mishra V, Geiran O, Fiane AE, Sørensen G, Andresen S, Olsen EK, Khushi I, Hagen TP.
    J Heart Lung Transplant; 2010 Jan 31; 29(1):72-8. PubMed ID: 19783175
    [Abstract] [Full Text] [Related]

  • 11. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK, Kondareddy S, Malik F, Wang IW, Mann DL, Ewald GA, Moazami N.
    Ann Thorac Surg; 2010 Oct 31; 90(4):1270-7. PubMed ID: 20868826
    [Abstract] [Full Text] [Related]

  • 12. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, Jansz P, Hayward CS.
    J Heart Lung Transplant; 2011 Aug 31; 30(8):888-95. PubMed ID: 21530314
    [Abstract] [Full Text] [Related]

  • 13. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND, Weiss ES, Schaffer J, Ullrich SL, Rivard DC, Shah AS, Russell SD, Conte JV.
    Ann Thorac Surg; 2008 Sep 31; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [Abstract] [Full Text] [Related]

  • 14. Hospital Readmissions After Continuous-Flow Left Ventricular Assist Device Implantation: Incidence, Causes, and Cost Analysis.
    Akhter SA, Badami A, Murray M, Kohmoto T, Lozonschi L, Osaki S, Lushaj EB.
    Ann Thorac Surg; 2015 Sep 31; 100(3):884-9. PubMed ID: 26095106
    [Abstract] [Full Text] [Related]

  • 15. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
    Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH.
    J Heart Lung Transplant; 2007 Aug 31; 26(8):815-8. PubMed ID: 17692785
    [Abstract] [Full Text] [Related]

  • 16. Costs associated with ventricular assist device use in children.
    Mahle WT, Ianucci G, Vincent RN, Kanter KR.
    Ann Thorac Surg; 2008 Nov 31; 86(5):1592-7. PubMed ID: 19049755
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients.
    Feller ED, Sorensen EN, Haddad M, Pierson RN, Johnson FL, Brown JM, Griffith BP.
    Ann Thorac Surg; 2007 Mar 31; 83(3):1082-8. PubMed ID: 17307463
    [Abstract] [Full Text] [Related]

  • 18. Extremes of body mass index do not impact mid-term survival after continuous-flow left ventricular assist device implantation.
    Brewer RJ, Lanfear DE, Sai-Sudhakar CB, Sundareswaran KS, Ravi Y, Farrar DJ, Slaughter MS.
    J Heart Lung Transplant; 2012 Feb 31; 31(2):167-72. PubMed ID: 22305378
    [Abstract] [Full Text] [Related]

  • 19. Heart transplantation versus continuous-flow left ventricular assist device: comprehensive cost at 1 year.
    Patel SR, Sileo A, Bello R, Gunda S, Nguyen J, Goldstein D.
    J Card Fail; 2015 Feb 31; 21(2):160-6. PubMed ID: 25433361
    [Abstract] [Full Text] [Related]

  • 20. Left ventricular device as destination therapy: are we there yet?
    Badiwala MV, Rao V.
    Curr Opin Cardiol; 2009 Mar 31; 24(2):184-9. PubMed ID: 19532106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.